Cover Image

A Randomized, Open-Label, Phase 2a Study to Assess the Safety, Pharmacodynamics, and Pharmacokinetics of YAQ007 Versus Rifaximin in Cirrhosis

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Authors:	Ballester, Maria Pilar, Carbonell-Asins, Juan, Elshabrawi, Ahmed, Rubin, Darren, Winkle, Peter, Lawitz, Eric, Stoici, Roxanna, Kayali, Zeid, Ortiz Lasanta, Grisell, Hassanein, Tarek, Jalan, Rajiv
Format:	Recurso digital
Published:	Zenodo 2026
Subjects:	Hepatic Encephalopathy Rifaximin Ammonia Ornithine Phenylacetate Cirrhosis
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Determination of rifaximine in milk of dairy cows using high pressure liquid chromatography (HPLC)
by: José Luis Ángeles Manjarrez
Published: (2012)

Síndrome de encefalopatía posterior reversible (PRES) en dos casos clínicos de eclampsia
by: Jorge Hasbún H.
Published: (2012)

Pharmacotherapy for Cirrhosis in Japan
by: Hiroki Nishikawa, et al.
Published: (2025)

Liver Cirrhosis and Sleep Disorders
by: Jiawen Feng, et al.
Published: (2025)

The Role of Magnesium in Liver Cirrhosis
by: Weiye Zeng, et al.
Published: (2025)

The Prognostic Significance of Handgrip Strength in Cirrhosis: Simplicity Is the Ultimate Sophistication
by: Binxin Cui, et al.
Published: (2025)

The Safety of Interferon‐Based Therapies in Chronic Hepatitis B Patients With Compensatory Cirrhosis
by: Qiran Zhang, et al.
Published: (2026)

The Dynamic Evolution of Lipid Profiles Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
by: Jiamin Xu, et al.
Published: (2026)

Radiomic Analysis of Contrast‐Enhanced CT Predicts Recompensation in Hepatitis B‐Related Decompensated Cirrhosis
by: Qiaofeng Chen, et al.
Published: (2025)

Microbubble‐Based Ultrasound Contrast Agents in Contrast‐Enhanced Ultrasonography for Managing Portal Hypertension in Cirrhosis
by: Danping Huang, et al.
Published: (2026)

Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma Located at Esophageal Varices Caused by Liver Cirrhosis
by: Wenlan Zheng, et al.
Published: (2025)

Predictive Value of Coagulation Factor VIII and Protein C Levels for Further Decompensated Events in Patients With Decompensated Cirrhosis
by: Siyu Jiang, et al.
Published: (2025)

Encefalopatía hepática
by: Juan Pablo Londoño Múnera
Published: (2008)

Serum Creatinine of 1.1 mg/dL Can Indicate Disease Deterioration and 90‐day Mortality in Hospitalized Patients With Cirrhosis in Chinese Population
by: Lindan Xie, et al.
Published: (2025)

Characterization of Liver Cirrhosis in Patients Hospitalized at a University Hospital in Colombia
by: Derly Milena Peña-Ramírez
Published: (2025)

Effects of Shunt Position on the Prognosis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhotic Esophagogastric Variceal Bleeding
by: Yi‐Han Yang, et al.
Published: (2025)

Correction to “Multifrequency Multiparameter Magnetic Resonance Elastography Applied to an In Vivo Porcine Model for Assessing Portal Hypertension”
Published: (2026)

Author Guidelines
Published: (2024)

One‐year status of hepatic venous pressure gradient measurement from 85 hospitals in China
by: Jitao Wang, et al.
Published: (2024)

Dawn of an era of effective treatments for MAFLD
by: Cameron Gofton, et al.
Published: (2024)

Massive Lower Gastrointestinal Bleeding Due to Colonic Telangiectasia
by: Xuan Ren, et al.
Published: (2024)

Molecular mechanisms of hepatic lipid metabolism disorders: Focus on mitochondrial quality control
by: Jiachi Yu, et al.
Published: (2024)

Issue Information
Published: (2025)

Endovascular embolization for upper gastrointestinal bleeding due to portal hypertension caused by a superior mesenteric arteriovenous fistula
by: Yu He, et al.
Published: (2024)

Serum markers for detecting histological features of autoimmune hepatitis and predicting prognosis in patients with antinuclear antibody‐positive drug‐induced liver injury
by: Feiyu Zhang, et al.
Published: (2024)

Correction to “Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)”
Published: (2026)

Application of subharmonic‐aided pressure estimation in a patient with giant hepatic cyst: A case report
by: Xiuyun Lu, et al.
Published: (2024)

Correction to “Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1”
Published: (2026)

Endoscopic ultrasound‐guided portal pressure gradient identifies patients with previously undiagnosed clinically significant portal hypertension
by: Jerome C. Edelson, et al.
Published: (2024)

Deep Learning‐Based Prediction of High‐Risk Gastroesophageal Varices Using Two‐Dimensional Shear Wave Elastography
by: Lan Wang, et al.
Published: (2025)

When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble
by: Yuying Chen, et al.
Published: (2026)

Current Cell/Organoid and Animal Models for Primary Sclerosing Cholangitis
by: Qigu Yao, et al.
Published: (2026)

Chinese Registry on Transjugular Intrahepatic Portosystemic Shunts (CN‐TIPS): Protocol for a Registry‐Based, Prospective Prognostic Study
by: Yi Xiang, et al.
Published: (2026)

Liver Fibrosis Tests and Outcomes of Bariatric Surgery in Morbidly Obese Patients With MASLD
by: Parinda Prathyajuta, et al.
Published: (2026)

Successful Embolization for Recurrent Encephalopathy Caused by Type II Abernethy Malformation
by: Hongliang Wang, et al.
Published: (2025)

Disease Burden of Liver Cancer and Its Underlying Etiologies Globally and in China From 1990 to 2021: Results From the Global Burden of Disease Study 2021
by: Jiaqi Ruan, et al.
Published: (2026)

Portal Hypertension—Noninvasive Multiparametric Ultrasound‐Based Criteria and Measurements
by: Kathleen Möller, et al.
Published: (2025)

Issue Information
Published: (2025)

Commentary on “Portal Hypertension‐Noninvasive Multiparametric Ultrasound Based Criteria and Measurements”
by: Yi Dong
Published: (2025)

Issue Information
Published: (2024)